Luca Springer retweeted
There's a 5% chance you have blood in your urine. 1 in 20 Americans do.
It usually turns out to be a UTI, kidney stone, or something benign.
Sometimes it's bladder cancer.
Standard protocol includes a cystoscopy: threading a thin camera through your urethra into your bladder.
For this and other "inconveniences" you push the question away...
You know something might be wrong, but confirming that requires time off of work, money out of your pocket, and a willingness to endure a slow and invasive process.
9 out of 10 at-risk patients never actually receive the guideline-recommended eval.
Cancer that could have been caught early is caught late (or not at all).
Traditional urine tests for bladder cancer test samples that were stored, frozen, or chemically preserved before being analyzed.
In other words, your bladder cancer test is based off a distorted version of what *was* present in the past.
And it’s not just bladder cancer!
Care across the board comes late and costs a lot, lowering the chance of detection, which lowers the chance of recovery.
This raises the costs of care for patients, providers, and the health systems that are already hanging on by a... thread.
Numen is a cancer detection technology company building at-home testing, risk assessment, and clinical decision support.
@numenbio develops the biology, chemistry, hardware, software, and models together, under one roof and in one cup.
Their first product is Atlas: a non-invasive, lab-grade, at-home urine test for bladder cancer.
Atlas returns a risk score to the patient's physician within minutes to better triage blood in the urine.
Compass is guideline-based decision support that helps physicians assess risk and determine the next step in care.
And Numen's clinical AI is built to learn from test results and clinical outcomes to improve disease detection and risk prediction over time.
Better data produces better models. Better models catch cancer earlier. The more cancer detected, the more cancer deaths prevented.
What Numen learns in bladder cancer will help it extend this approach across urology and into other areas of care.
Numen is engineering the infrastructure to drive cancer mortality to zero.
Building @numenbio with @_tom_dot_com to engineer a future without cancer deaths. Find out more below in an interview with our partners at @TQVentures!
A cancer test that runs inside a cup. Taken at home, with results sent to your doctor in 30 minutes. Built in a San Francisco lab by a team that started in a shipping container.
What it actually takes to build it:
“If we spend ten, 20, 30, 40 years working on this, that’s okay. The outcome will be worth it.”
@luca_springer, co-founder and CEO of @numenbio
Timestamps:
00:00 Welcome to Numen
00:56 Why catch cancer early
01:24 The first lab was a shipping container
02:28 What the data unlocks next
03:23 National team MVP to founder
04:13 Why bladder cancer first
05:33 The candle prototype
06:25 Meet Atlas, a lab in a cup
06:55 NASA engineers under one roof
07:32 The Viennese café
08:08 Pipette pong
08:46 From the dungeon to Golden Gate Park
09:28 The only milestone that matters
09:59 40 years on one problem
Luca Springer retweeted
Proud to be building @numenbio with @luca_springer and with great backers like @TQVentures in our corner!
A cancer test that runs inside a cup. Taken at home, with results sent to your doctor in 30 minutes. Built in a San Francisco lab by a team that started in a shipping container.
What it actually takes to build it:
“If we spend ten, 20, 30, 40 years working on this, that’s okay. The outcome will be worth it.”
@luca_springer, co-founder and CEO of @numenbio
Timestamps:
00:00 Welcome to Numen
00:56 Why catch cancer early
01:24 The first lab was a shipping container
02:28 What the data unlocks next
03:23 National team MVP to founder
04:13 Why bladder cancer first
05:33 The candle prototype
06:25 Meet Atlas, a lab in a cup
06:55 NASA engineers under one roof
07:32 The Viennese café
08:08 Pipette pong
08:46 From the dungeon to Golden Gate Park
09:28 The only milestone that matters
09:59 40 years on one problem
Luca Springer retweeted
A cancer test that runs inside a cup. Taken at home, with results sent to your doctor in 30 minutes. Built in a San Francisco lab by a team that started in a shipping container.
What it actually takes to build it:
“If we spend ten, 20, 30, 40 years working on this, that’s okay. The outcome will be worth it.”
@luca_springer, co-founder and CEO of @numenbio
Timestamps:
00:00 Welcome to Numen
00:56 Why catch cancer early
01:24 The first lab was a shipping container
02:28 What the data unlocks next
03:23 National team MVP to founder
04:13 Why bladder cancer first
05:33 The candle prototype
06:25 Meet Atlas, a lab in a cup
06:55 NASA engineers under one roof
07:32 The Viennese café
08:08 Pipette pong
08:46 From the dungeon to Golden Gate Park
09:28 The only milestone that matters
09:59 40 years on one problem
We’ve been building quietly at @numenbio for the past few years. Tomorrow we’re sharing more for the first time, in a conversation with Schuster at @TQVentures.
Here’s a teaser; full interview tomorrow.
Inside the lab engineering a future without cancer deaths.
Tomorrow: @numenbio with @luca_springer.
Inside the lab engineering a future without cancer deaths
Numen is engineering a future without cancer deaths. This is the second episode of House Calls, a Bourdain-style documentary series filmed in the places that shape how founders build.
Luca Springer retweeted
A startup doesn't have to be your life's work, but if it is, you become much harder to defeat. You play the long game and you outlast everyone. Because practically everyone else is an opportunist by comparison.
Luca Springer retweeted
The Iso team has cooked something incredible: our new technical report unveils the latest results from our drug design engine, the IsoDDE, progressing far beyond AlphaFold 3. This breaks new ground compared to AF and other similar methods by a significant degree across all key benchmarks. 1/7
Luca Springer retweeted
New science from Richard Zhou... When our blood cells lyse, they release haemoglobin, which is dangerous to our body. We detoxify this by binding it to a serum protein, haptoglobin and taking it up into macrophages, using the receptor CD163. Richard showed how CD163 works!
Super excited to announce that Cleancard is part of @ycombinator’s summer batch!
Cleancard (YC S23) combines synthetic biology and artificial intelligence to make at-home cancer screens that are as easy to use as a pregnancy test.
ycombinator.com/launches/JEj…
Congrats on the launch, @_tom_dot_com and @luca_springer!
1
13
2,639
Luca Springer retweeted
Cleancard (YC S23) combines synthetic biology and artificial intelligence to make at-home cancer screens that are as easy to use as a pregnancy test.
ycombinator.com/launches/JEj…
Congrats on the launch, @_tom_dot_com and @luca_springer!
Luca Springer retweeted
So happy my main PhD work is now out @Cancer_Cell. We found biomarkers (TMB+TMC) that identify which patients with inoperable esophageal cancer (and some forms of gastric cancer) are likely to benefit most from immunotherapy. Tweetorial below, pls share! sciencedirect.com/science/ar…
Luca Springer retweeted
To solve the world’s hardest problems, we must strengthen democratic values, collaboration, and security as technology reshapes our world.
Today, we’re excited to announce the 2023 cohort of International Strategy Forum Fellows.
Read more:
schmidtfutures.com/schmidt-f…
Luca Springer retweeted
1/We think the biggest company in the world will be a consumer health tech company. Four of the top five biggest companies in the world are consumer companies, and healthcare is one of the nation’s biggest industries. @daisydwolf @a16z @a16zBioHealth
a16z.com/2022/11/11/the-bigg…


















